Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference
NEW HAVEN, Conn., Nov. 21, 2011 (GLOBE NEWSWIRE) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that members of the Company’s executive team will present at the upcoming 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at 11:00 a.m. EST at The New York Palace Hotel, in New York, NY.
The live audio broadcasts and the subsequent archived webcasts of the Company’s presentations will be available on the Company’s website, http://www.achillion.com, under the “News Center” section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion’s website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.
About Achillion Pharmaceuticals
Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion’s proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including hepatitis C and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.